Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 12 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HARTE HANKS INC | 25,000 | reported | 02 Jun 2025 | tx 14+102,729 |
| ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | 21,900 | reported | 06 Dec 2012 | tx 49+101,108.547−1,008.547 |
| TECOGEN INC. | 6,362 | reported | 16 May 2016 | tx 6+16,362 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jun 2025 | GRANT_AWARD | HARTE HANKS INC | 25,000 | 4.55 USD | |
| 25 Nov 2024 | PURCHASE | HARTE HANKS INC | 850 | 5.81 USD | |
| 18 Nov 2024 | PURCHASE | HARTE HANKS INC | 45 | 6.54 USD | |
| 18 Nov 2024 | PURCHASE | HARTE HANKS INC | 25 | 6.54 USD | |
| 18 Nov 2024 | PURCHASE | HARTE HANKS INC | 69 | 6.59 USD | |
| 18 Nov 2024 | PURCHASE | HARTE HANKS INC | 1,500 | 6.50 USD | |
| 18 Nov 2024 | PURCHASE | HARTE HANKS INC | 1,441 | 6.60 USD | |
| 18 Nov 2024 | PURCHASE | HARTE HANKS INC | 765 | 6.65 USD | |
| 18 Nov 2024 | PURCHASE | HARTE HANKS INC | 59 | 6.40 USD | |
| 12 Aug 2024 | PURCHASE | HARTE HANKS INC | 400 | 6.92 USD | |
| 12 Aug 2024 | PURCHASE | HARTE HANKS INC | 3,750 | 7.05 USD | |
| 12 Aug 2024 | PURCHASE | HARTE HANKS INC | 100 | 6.86 USD | |
| 13 May 2024 | PURCHASE | HARTE HANKS INC | 4,125 | 7.20 USD | first after silence |
| 30 Jan 2024 | GRANT_AWARD | HARTE HANKS INC | 64,600 | 7.74 USD | deriv |
| 16 May 2016 | GRANT_AWARD | TECOGEN INC. | 6,362 | 3.93 USD | deriv |
| 28 May 2015 | PURCHASE | TECOGEN INC. | 400 | 4.30 USD | |
| 29 May 2015 | PURCHASE | TECOGEN INC. | 100 | 4.30 USD | |
| 01 Jun 2015 | PURCHASE | TECOGEN INC. | 1,000 | 4.32 USD | |
| 02 Dec 2014 | PURCHASE | TECOGEN INC. | 4,050 | 5.54 USD | |
| 26 Nov 2014 | PURCHASE | TECOGEN INC. | 4,450 | 5.74 USD | first after silence |
| 05 Dec 2012 | GRANT_AWARD | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | 100 | 2.46 USD | |
| 05 Dec 2012 | GRANT_AWARD | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | 100 | 2.47 USD | |
| 05 Dec 2012 | GRANT_AWARD | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | 20 | 2.50 USD | |
| 06 Dec 2012 | GRANT_AWARD | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | 1,600 | 2.58 USD | |
| 05 Dec 2012 | GRANT_AWARD | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | 1,205 | 2.53 USD |
4 purchases reported after at least 12 months of silence — most recent on 13 May 2024.